Business · 05/09/2024Updated: 10/17/2026 · 1 min read
FDA Releases Updated Guidance on Nitrosamine Impurities in Human Drugs
Summary
The FDA has released a final guidance for industry on controlling nitrosamine impurities in pharmaceutical products, updating previous guidance issued in 2021.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →